semaglutide weight loss graph Ozempic and Wegovy: Are These Popular Diabetes and Drugs Associated with Increases in Serious Side Effects? Weight loss efficacy of selected

It may help maintain weight loss after GLP1 tapering in the first few months, but its use is often limited to short-term, in part because it is a schedule IV controlled substance due to its stimulant nature and has potential for abuse

Inactive Ingredients: Polybutene, Caprylic/Capric Triglyceride, Helianthus Annuus (Sunflower) Seed Wax, C9-12 Alkane, Diisostearyl Malate, Euphorbia Cerifera (Candelilla) Wax, Tridecyl Trimellitate, Bis-behenyl/Isostearyl/Phytosteryl Dimer Dilinoleyl Dimer Dilinoleate, Glyceryl Isostearate, Hydrogenated Polyisobutene, Dimethicone, Butyrospermum Parkii (Shea) Butter, Bis-diglyceryl Polyacyladipate-2, Zea Mays Oil, Polyhydroxystearic Acid, Lecithin, Ascorbic Acid, N-acetyl-d-glucosamine, Linoleic Acid, Punica Granatum (Pomegranate) Sterols, Dipalmitoyl Hydroxyproline, Disteardimonium Hectorite, Squalane, Polysilicone-11, Sodium Hyaluronate, Tocopheryl Acetate, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Moringa Oil/Hydrogenated Moringa Oil Esters, Amaranthus Caudatus Seed Oil, Hordeum Distichon (Barley) Extract, Triticum Vulgare (Wheat) Germ Oil, Triethyl Citrate, Citrus Aurantium Peel Oil, Flavor, C12-15 Alkyl Benzoate, Polyricinoleic Acid, Vanillin, Sorbitan Laurate, C18-36 Acid Glycol Ester, C18-36 Acid Triglyceride, Tocopherol

The following sections break down each scenario

EPIDEMIOLOGY AND DISEASE BURDEN OF MASLD/MASH MASLD is estimated to impact around 32.4% of adults across the world and is currently considered the leading chronic liver disease globally, with estimates exceeding one billion individuals affected [13,14]